DP1

Dược phẩm Trung ương CPC1 ·UPCOM ·2026Q1

▼ Under pressure

Margins remain under pressure Net margin 4.69%, −1.64pp YoY
Price
33,900
Latest close
03 Jun 2026
P/E 6.84x
P/B 1.16x
EPS 4,955
BVPS 29,158
ROE 18.0%
ROA 6.2%
Profit Margin 4.7%
Asset Turnover 1.32x
Equity Mult. 2.91x

TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity

What Is Changing

On a TTM 2026Q1 basis, DP1 is declining across multiple metrics versus the same period, suggesting current pressure is not coming from just one side — the growth momentum has held across consecutive periods. More notably, operating cash flow is significantly negative relative to profit — this is pressure that needs close monitoring.

TTM REVENUE
VND 2,219bn
+10.6%YoY
NET MARGIN
4.69%
−1.6ppYoY
TTM NET PROFIT
VND 104bn
−18.1%YoY
CFO / Net Income
-1.17x
negative cash flow vs profit
Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24 Q4'23 Q3'23 Q2'23
Revenue 569.3 588.5 513.2 547.6 485.1 527.0 479.7 514.8 506.3 623.5 540.7 499.6
Growth -3% +15% -6% +13% -8% +10% -7% +2% -19% +15% +8%
Net Income 22.0 14.1 45.4 22.5 31.2 25.9 47.6 22.3 35.9 32.6 32.7 17.9
Net Margin 3.87% 2.39% 8.85% 4.10% 6.42% 4.92% 9.92% 4.33% 7.08% 5.23% 6.04% 3.58%

Drivers of DP1's profit

TTM

Net profit attributable to parent declined vs last year, mainly due to lower gross profit. Supporting and offsetting drivers:

Finance costs ↓ 15.4bn
Other profit ↑ 9.9bn
Tax ↓ 7.6bn
Financial income ↑ 3.6bn
Gross profit ↓ 49.5bn
Selling expenses ↑ 16.0bn
TTM

Net profit attributable to parent declined vs prior quarter, mainly due to lower gross profit. Supporting and offsetting drivers:

Finance costs ↓ 8.1bn
Tax ↓ 2.3bn
Administrative expenses ↓ 1.2bn
Gross profit ↓ 15.6bn
Financial income ↓ 2.6bn
Selling expenses ↑ 2.6bn

Financial Highlights

Detailed analysis of each financial dimension

ROE = Profit Margin × Asset Turnover × Equity Multiplier

2025Q1 27.3% = 6.3% × 1.58 × 2.73
2026Q1 18.0% = 4.7% × 1.32 × 2.91

ROE fell from 27.3% to 18.0% — asset turnover weakened the most, though leverage still provided support.

Net margin: 4.7% -1.6pp Asset turnover: 1.32x -0.26x Leverage: 2.91x +0.17x

Is the profit sustainable?

Margins narrowed but earnings quality remains clean — pressure is mainly operational.

very positive positive stable watch under pressure

What is driving the margin?

Net margin fell to 4.69%, losing 1.6pp. The main pressure is Gross margin fell 3.8pp, outweighing the improvement in SG&A / Revenue fell 0.2pp (with additional support from Net financial result / Revenue rose 1.0pp and Other profit / Revenue rose 0.3pp).

The pressure comes from core operations — this is a concerning type of decline, not a one-off movement.

Profitability trend

Net Margin 4.69% −1.6pp
Gross Margin 12.31% −3.8pp
SG&A / Revenue 8.04% −0.2pp

TTM YoY · 2025Q1 -> 2026Q1

Is capital being used efficiently?

Capital efficiency is declining — check whether the drag is from margins or turnover.

Is capital being deployed efficiently?

ROIC fell to 7.16%, losing 6.4pp. That translates to 7.16 in after-tax operating profit for every 100 units of operating capital. Both NOPAT margin narrowed 2.1pp and capital turnover fell 0.37x, while invested capital expanded strongly by 238bn — pressure came from both operational efficiency and asset efficiency.

Pressure came from the margin side — core operations are weakening, not just a temporary asset-management issue.

CAPITAL EFFICIENCY TREND

TTM YoY · 2025Q1 -> 2026Q1

ROIC 7.16% −6.4pp
NOPAT Margin 3.35% −2.1pp
Capital Turnover 2.14x −0.37x
Average Invested Capital 1,039.1bn +238.3bn

Balance Sheet

ROIC declined — the balance sheet shows how capital is being deployed. Capital structure is balanced — liabilities at 2.27x equity, net debt at 0.91x equity.

Inventory ended the period at 1,032.7bn, roughly 53.6% of total assets.

Over the last 12 months, working capital absorbed 205.7bn of cash, mainly because of higher receivables and higher inventories. Part of that drag was offset by higher payables.

Working Capital Drivers

TTM YoY · 2025Q1 -> 2026Q1

Receivables increased → lower CFO: −166.7bn
Inventories increased → lower CFO: −277.7bn
Payables increased → higher CFO: +238.7bn

Working Capital Efficiency

Cash conversion cycle lengthened by 25.4 days versus the same period last year. The main moves came from DIO rose 41.7 days, DSO rose 1.9 days, and DPO rose 18.2 days.

Working capital cycle lengthened mainly due to slower inventory turnover — more capital is being tied up in inventory.

Watchpoints

Cash conversion cycle remains stretched

CCC stands at 156.9 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Receivables collection is slowing

DSO increased by +1.9 days, pointing to slower receivables turnover.

Working Capital Efficiency

TTM YoY · 2025Q1 -> 2026Q1

Receivables 102.9 days +1.9 days
Inventory 157.1 days +41.7 days
Payables 103.0 days +18.2 days
Cash Conversion Cycle 156.9 days +25.4 days

Is financial risk significant?

Check leverage, liquidity, and cash-flow conversion.

Leverage & Liquidity

Leverage is balanced for now, with net debt / equity at 0.91x and interest coverage at 2.64x.

At present, short-term debt accounts for 100.0% of total debt, cash equals 2.6% of debt, and total debt stands at 574.8bn.

Watchpoints

Short-term refinancing pressure is meaningful

Short-term debt accounts for 100.0% of total debt, raising near-term refinancing needs.

Cash buffer is thin relative to debt

Cash / debt stands at 2.6%, leaving limited liquidity buffer to monitor.

Leverage and liquidity trend

Net Debt / Equity 0.91x +0.24x
Interest Coverage 2.64x −0.06x
Cash / Debt 2.6% +0.4pp
Short-term Debt / Total Debt 100.0% 0.0pp
CFO / NI -1.17x −0.99x

TTM YoY · 2025Q1 -> 2026Q1

Cash Flow

Operating cash flow reached -142.4bn in 2025, against investing cash flow of -54.3bn.

Post-investment cash flow was negative +196.7bn. Financing cash flow was positive +238.9bn.

CFO / net income was -1.17x.

Track how much investment can be funded internally from operating cash flow.

Cash capex or FCF data is incomplete, so the cash-conversion view is only partial.

Cash Conversion

TTM Cash Conversion · 2025Q1 -> 2026Q1

CFO TTM 121.7bn −98.6bn
Cash Capex
FCF TTM

Investment Takeaway

The business is showing a few weaker signals, but the current magnitude is not yet clear enough to conclude that this is a broader weakening phase. The next item to monitor is the earnings mix, when non-core contribution is 29.8%. The main risk still sits in core profitability, with net margin down 1.6 pp.

Watchpoint: the earnings mix still needs monitoring, with net financial result still accounting for 29.8% of PBT and CFO / net income currently at -1.17x.

Key risk: profitability remains under pressure, with trailing-12M net margin at 4.69% after a 1.6pp decline versus the same period last year.

Statement Data

Item 2025 2024 2023 2022 2021
Net Revenue
2,134.4 2,025.7 2,158.4 2,159.5 2,182.4
Cost of Goods Sold
1,845.6 1,714.6 1,805.2 1,865.7 0.0
Gross Profit
288.8 311.1 353.2 293.7 248.6
Financial Expenses
42.4 41.4 57.5 59.4 -31.5
Selling Expenses
140.2 131.1 130.8 146.3 -138.5
General and Administrative Expenses
36.8 42.4 36.4 36.0 -42.1
Operating Profit
102.0 119.1 145.0 65.2 57.6
Profit Before Tax
140.5 144.2 145.1 65.5 56.9
Net Income
113.1 113.8 115.9 50.5 45.0
Profit Attributable to Parent
113.1 113.8 115.9 50.5 45.0
Earnings per Share
4,866.00 4,878.00 4,809.00 2,129.00 2,061.00

Explore Other Stocks In The Same Sector

TTD, JVC, CDP, YTC, TNH

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.